The Use of Belladonna and Opium (B&O) Suppository in the Treatment of Postoperative Stent Pain: A Randomized, Double-Blinded Control Study

NCT03332056 Phase 4 COMPLETED Results posted

The purpose of this study is to determine if preemptive B\&O suppository placement will decrease post-operative pain in patients undergoing ureteral stent placement.

Details

Lead sponsor	University of Washington
Phase	Phase 4
Status	COMPLETED
Enrolment	71
Start date	2013-08
Completion	2015-10

Conditions

• Nephrolithiasis

Interventions

• Belladonna and Opium
• Placebo suppository

Primary outcomes

• Global Quality of Life Score on Postoperative Day 1 — postoperative day 1
  Global quality of life score as measured by the Ureteral Stent Symptom Questionnaire (USSQ). Scale is 1-7 (Lower score indicating better quality of life compared to higher score). 1 = delighted, 2 = pleased, 3 = mostly satisfied, 4 = mixed feelings (about equally satisfied and dissatisfied), 5 = mostly dissatisfied, 6 = unhappy, 7 = terrible
• Global Quality of Life Score on Postoperative 3 — postoperative day 3
  Global quality of life score as measured by the Ureteral Stent Symptom Questionnaire (USSQ). Scale is 1-7 (Lower score indicating better quality of life compared to higher score). 1 = delighted, 2 = pleased, 3 = mostly satisfied, 4 = mixed feelings (about equally satisfied and dissatisfied), 5 = mostly dissatisfied, 6 = unhappy, 7 = terrible